Investigations

1st investigations to order

TSH

Test
Result
Test

Initial test for patients presenting with a thyroid nodule.[1] Usually normal.

A suppressed (lower than normal) thyroid-stimulating hormone (TSH) level suggests hyperthyroidism or the possibility of a hyperfunctioning (hot) nodule. The incidence of carcinoma in hyperfunctioning thyroid nodules is very low.

If TSH is normal or elevated, the next diagnostic step is ultrasound and fine-needle aspiration (FNA) of the thyroid nodule.[1]

Consider asking patients about their biotin (vitamin B7) intake, as a high consumption from dietary supplements may lead to falsely high or low thyroid function test results.[55][56][57]​​​

Result

normal (0.4 to 4.0 mIU/L)

thyroid/neck ultrasound

Test
Result
Test

An ultrasound should be performed in all patients with a thyroid nodule to confirm its presence, and assess size, location, and cystic component(s).[1][29][40][41] Ultrasound evaluation of the cervical lymph nodes should also be performed.[1][41][42]

Thyroid ultrasound and Doppler defines dimensions of nodules and solid/cystic component(s).[1][29][40][41]

Ultrasound-based risk stratification systems can be used to inform decisions on when to perform a fine-needle aspiration (FNA).[11][43]​​[44]​ The American College of Radiology Thyroid Imaging, Reporting, and Data System (ACR TI-RADS) classifies nodules based on ultrasound features as benign, not suspicious, mildly suspicious, moderately suspicious, or highly suspicious for malignancy (TR1 to TR5).[11] See Classification. Each risk stratification system has its own guidance on the threshold for FNA.​

Features suspicious for malignancy include micro-calcifications, a more-tall-than-wide shape, marked hypoechogenicity, or irregular margins.[11][47][58]

Ultrasound can be used to guide FNA of suspicious nodules.

Also used to pre-operatively evaluate cervical lymph nodes in patients with medullary cancer.[4]

Result

may show characteristics of a benign, mildly suspicious, moderately suspicious, or highly suspicious thyroid nodule; may show cervical lymphadenopathy

fine-needle aspiration (FNA)

Test
Result
Test

Done if thyroid-stimulating hormone (TSH) is normal or elevated.

FNA of thyroid nodules <1 cm is not recommended unless ultrasound findings are suspicious for malignancy or the patient has a high-risk history.[1][29]

Ultrasound-based risk stratification systems (e.g., American College of Radiology Thyroid Imaging, Reporting, and Data System [ACR TI-RADS]) can be used to inform decisions on when to perform an FNA.[11][43]​​​[44][59]​​​ FNA is recommended for highly suspicious nodules 1 cm or larger.[11]​ See Classification.

The Bethesda System for Reporting Thyroid Cytopathology (BSRTC) is commonly used to report FNA cytology findings, and is recommended by the American Thyroid Association.[1] The Bethesda system includes six diagnostic categories with an implied cancer risk that recommends the next clinical management step.[8] See Classification.

Cytology may identify the thyroid cancer type.[46] However, for follicular or oncocytic neoplasms, cytology does not distinguish between adenoma (benign) and carcinoma.[47][48]​ In these cases, molecular testing or surgery (e.g., lobectomy) to look for capsular or vascular invasion is required to confirm a diagnosis.[29][49]

Papillary cancer: intranuclear holes and grooves, 'Orphan Annie' eyes, and psammoma bodies.[29][Figure caption and citation for the preceding image starts]: Histopathology of papillary carcinoma, thyroid: a psammoma body is visible (arrow)CDC Image Library/Dr Edwin P. Ewing, Jr [Citation ends].com.bmj.content.model.Caption@6dbe0e22

Follicular neoplasms: hypercellularity, microfollicles, and absence of colloid.[Figure caption and citation for the preceding image starts]: Histopathology of follicular carcinoma, thyroidCDC Image Library/Dr Edwin P. Ewing, Jr [Citation ends].com.bmj.content.model.Caption@23542d29

Anaplastic thyroid cancer: wide variations in appearance; subtypes show spindle cell pattern, pleomorphic giant cell pattern, and squamoid pattern; use of special stains or immunohistochemical studies may be required to exclude other treatable entities with better prognoses.[13]

Medullary cancer: eosinophilic cells arranged in nests or sheets separated by amyloid and vascular stroma. Immunohistochemical staining positive for calcitonin.[4][Figure caption and citation for the preceding image starts]: Medullary thyroid cancer: H&E stain showing nests of tumour cellsMohan V et al. BMJ Case Reports CP 2019;12:e230446; used with permission [Citation ends].com.bmj.content.model.Caption@28576556

Lymphoma may be identified by flow cytometry and nuclear atypia.[50]

Result

cytology may suggest malignancy

Investigations to consider

molecular testing of cytology specimens

Test
Result
Test

Molecular testing of FNA specimens may be performed to detect genomic mutations/alterations (e.g., BRAF V600, MET, RET/PTC, NTRK, RAS, PAX8::PPARG) to enhance interpretation of indeterminate cytology findings (including follicular or oncocytic neoplasms) and to help guide treatment decisions.[37]

Result

may show genetic alterations associated with malignancy

free T4

Test
Result
Test

Required if thyroid-stimulating hormone (TSH) is abnormal (suppressed). Elevated free T4 suggests hyperthyroidism.

If free T4 is not available, an alternative test is total T4 plus a measure of binding.

Consider asking patients about their biotin (vitamin B7) intake, as a high consumption from dietary supplements may lead to falsely high or low thyroid function test results.[55][56][57]

Result

normal (0.8 to 1.8 nanograms/dL)

free T3

Test
Result
Test

Required if thyroid-stimulating hormone (TSH) is abnormal (suppressed). Elevated free T3 suggests hyperthyroidism.

If free T3 is not available, an alternative test is total T3 plus a measure of binding.

Consider asking patients about their biotin (vitamin B7) intake, as a high consumption from dietary supplements may lead to falsely high or low thyroid function test results.[55][56][57]

Result

normal (2.3 to 4.2 picograms/mL for free T3; 80 to 180 nanograms/dL for total T3).

laryngoscopy

Test
Result
Test

Vocal cord mobility should be examined in patients with voice change/hoarseness.[1]

Laryngoscopy, which may show a paralysed vocal cord, is recommended in patients with pre-operative voice abnormalities and in patients with gross extrathyroidal extension of cancer posteriorly or extensive nodal involvement, even if the voice is normal.[1]

A paralysed vocal cord is highly suggestive of malignancy.

Result

may show ipsilateral paralysed vocal cord

I-123 thyroid scan and uptake

Test
Result
Test

Scan should be ordered for patients with overt or subclinical hyperthyroidism. A hyperfunctioning (hot) nodule is almost always benign.

Most nodules are hypofunctioning (cold). Most of these are benign, but malignant nodules are also cold.

Result

hot or cold nodule

core biopsy

Test
Result
Test

When fine-needle aspiration suggests lymphoma.[50]

Core biopsy is not recommended for the initial identification and evaluation of thyroid lesions.[51][52]

Result

may confirm lymphoma

CT neck

Test
Result
Test

Used for preoperative evaluation of cervical lymph nodes in patients with medullary cancer.[4] 

Occasionally needed to evaluate large or rapidly expanding neck masses (e.g., suspected lymphomas).

Result

may show cervical lymphadenopathy

serum calcitonin

Test
Result
Test

Ordered if medullary thyroid carcinoma is confirmed or suspected (e.g., on cytology or when there is a family history suggestive of familial medullary cancer or a multiple endocrine neoplasia [MEN] syndrome).[4][37]

Result

high (>10 nanograms/L) in medullary thyroid carcinoma

genetic testing for familial syndromes

Test
Result
Test

Required for patients with a family history of multiple endocrine neoplasia (MEN) syndromes or a cytologic diagnosis of medullary thyroid cancer.[4][37]

Almost all patients with MEN type 2A (MEN2A), MEN2B, or isolated familial medullary thyroid cancer have germline RET (REarranged during Transfection) mutations, and around 50% of sporadic medullary thyroid cancers have somatic RET mutations.[4]

The RET proto-oncogene codes for a tyrosine kinase receptor, which is expressed in neural crest-derivative tissues.[29]

Different types of RET mutation account for different biological behaviour and may guide future management (such as screening for, and treatment of, pheochromocytoma and hyperparathyroidism).[53]

Result

may detect RET mutations

serum thyroglobulin

Test
Result
Test

Useful for post-treatment monitoring of papillary or follicular (including oncocytic) thyroid cancer, but not for diagnosis of thyroid malignancy.

It is also useful for predicting future disease-free status before post-operative radioiodine therapy for remnant ablation, whereby low pre-ablation thyroglobulin levels may be considered a favourable risk factor in patients with differentiated thyroid cancer.[54] 

Result

may be low or elevated

Emerging tests

translaryngeal ultrasound

Test
Result
Test

An emerging modality to evaluate vocal cords pre-operatively. If there is an abnormality seen on vocal cord ultrasonography, this can then be followed by fibre-optic laryngoscopy.

A non-invasive technique that can be performed at the surgery visit.[60]

Result

may show abnormal vocal cord movement

sentinel node biopsy

Test
Result
Test

Sentinel node biopsy using blue dye, radioisotope, or combined techniques has been trialled in people with clinically node-negative thyroid cancer. Results are variable and it is still considered investigational.[60][61][62][63]

Result

positive

Use of this content is subject to our disclaimer